Ridgetech (FRA:7QL) EPS without NRI: €-50.41 (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7QL Ridgetech Inc FRA:7QL
40 GF Score
Price €20,304.00
GF Value €2,118,249.18
! 5 Warning Signs
View Full Analysis

What is Ridgetech EPS without NRI?

Ridgetech FRA:7QL 40 EPS without NRI is €-50.41 as of Sep. 2025. GuruFocus rates FRA:7QL with a GF Score™ of 40/100 and a GF Value™ of €2,118,249.18. The stock has 5 warning signs investors should review. Among 509 Healthcare Providers & Services companies, Ridgetech ranks better than 93.91% on this metric.

Ridgetech's earnings per share without non-recurring items for the six months ended in Sep. 2025 was €-1.31. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2025 was €-50.41.

During the past 3 years, the average earnings per share (NRI) Growth Rate was 75.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Ridgetech's EPS without NRI or its related term are showing as below:

FRA:7QL' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -55   Med: 13.4   Max: 75.4
Current: 75.4

During the past 13 years, Ridgetech's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 75.40% per year. The lowest was -55.00% per year. And the median was 13.40% per year.

FRA:7QL's 3-Year EPS without NRI Growth Rate is ranked better than
93.91% of 509 companies
in the Healthcare Providers & Services industry
Industry Median: 11.7 vs FRA:7QL: 75.40

Ridgetech's EPS (Diluted) for the six months ended in Sep. 2025 was €-1.28. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was €312.30.

Ridgetech's EPS (Basic) for the six months ended in Sep. 2025 was €-1.28. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2025 was €312.30.


Ridgetech  (FRA:7QL) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Ridgetech EPS without NRI Related Terms


Ridgetech EPS without NRI Historical Data

* Premium members only.

The historical data trend for Ridgetech's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ridgetech EPS without NRI Chart

Ridgetech Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5,931.30 -2,411.84 -3,857.29 70.85 -36.54

Ridgetech Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.83 -264.12 12.23 -49.09 -1.31

FRA:7QL vs DHTI, PMHS, BLMH: EPS without NRI Comparison

For the Pharmaceutical Retailers subindustry, Ridgetech's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ridgetech PE Ratio without NRI vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Ridgetech's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Ridgetech's PE Ratio without NRI falls into.


FRA:7QL
40GF Score
Ridgetech Inc FRA:7QL
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ridgetech EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-50.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €-50.41 mean?
Ridgetech (FRA:7QL) has a EPS without NRI of €-50.41 as of Sep. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Ridgetech and its competitors. According to the industry distribution chart, Ridgetech ranks #31 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 6.1%.
Is Ridgetech's EPS without NRI too high?
Ridgetech's current EPS without NRI is €-50.41. Based on the distribution chart, Ridgetech ranks #31 out of 509 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Ridgetech has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Ridgetech's EPS without NRI compare to DHTI and PMHS?
According to the Healthcare Providers & Services industry distribution chart, Ridgetech ranks #31 out of 509 companies for EPS without NRI. This places Ridgetech in the top 6% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 11.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Healthcare Providers & Services company?
The median EPS without NRI among Healthcare Providers & Services companies is 11.70, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Ridgetech and its competitors. For the Healthcare Providers & Services industry, the median EPS without NRI is 11.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ridgetech's current EPS without NRI is €-50.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ridgetech stock overvalued right now?
Ridgetech (FRA:7QL) has a current EPS without NRI of €-50.41. The stock's GF Value™ is €2,118,249.18, compared to a current price of €20,304.00 — trading 99% below its estimated fair value. The current EPS without NRI is €-50.41. Ridgetech's overall GF Score™ is 40/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Ridgetech (FRA:7QL), the current EPS without NRI is €-50.41 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ridgetech (FRA:7QL) Overvalued in 2026?

Based on GuruFocus' analysis, Ridgetech stock appears to be undervalued. The current stock price of €20,304.00 is trading 99% below its estimated GF Value™ of €2,118,249.18.

Key valuation signals for FRA:7QL:

  • EPS without NRI: €-50.41
  • GF Value™: €2,118,249.18 vs. price of €20,304.00 (99% below fair value)
  • GF Score™: 40/100 with 5 warning signs

No single metric tells the full story. See the FRA:7QL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Ridgetech Business Description

Other Exchanges RDGT:USA
Address 18th Street, 5th Floor, Building 6, No. 100, Baiyang Sub-district, Qiantang District, Zhejiang Province, Hangzhou, CHN, 310008
Ridgetech Inc formerly China Jo-Jo Drugstores Inc is a retailer and distributor of pharmaceutical products. The company's operating segments include Retail drugstores, Online Pharmacy, and Drug wholesale. Retail drugstores segment sells prescription and over-the-counter medicines, TCM, dietary supplements, medical devices, and sundry items to retail customers. The online pharmacy segment sells drugs through third-party platforms such as Alibaba's Tmall, JD.com, and Amazon.com. It generates maximum revenue from the Retail drugstores segment.
40GF Score

Get the complete analysis for FRA:7QL

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20,304.00
Price
€2,118,249.18
GF Value